869 related articles for article (PubMed ID: 12834312)
21. Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.
Knitlova J; Hajkova V; Voska L; Elsterova J; Obrova B; Melkova Z
PLoS One; 2014; 9(12):e114374. PubMed ID: 25486419
[TBL] [Abstract][Full Text] [Related]
22. Smallpox, vaccination and adverse reactions to smallpox vaccine.
Wollenberg A; Engler R
Curr Opin Allergy Clin Immunol; 2004 Aug; 4(4):271-5. PubMed ID: 15238792
[TBL] [Abstract][Full Text] [Related]
23. [Validity of a telephone survey for determining the prevalence of atopic dermatitis and its seasonal variation in Spain].
García-Díez A; Puig L; Ortiz J; Blanco A
Actas Dermosifiliogr; 2009 May; 100(4):298-306. PubMed ID: 19463233
[TBL] [Abstract][Full Text] [Related]
24. Eczema herpeticum and eczema vaccinatum in children.
Jen M; Chang MW
Pediatr Ann; 2010 Oct; 39(10):658-64. PubMed ID: 20954612
[No Abstract] [Full Text] [Related]
25. Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities.
Mortz CG; Andersen KE; Dellgren C; Barington T; Bindslev-Jensen C
Allergy; 2015 Jul; 70(7):836-45. PubMed ID: 25832131
[TBL] [Abstract][Full Text] [Related]
26. [Eczema vaccinatum].
Heitmann HJ
Fortschr Med; 1972 May; 90(14):530-2. PubMed ID: 5072272
[No Abstract] [Full Text] [Related]
27. Estimating the Size of the U.S. Population at Risk of Severe Adverse Events from Replicating Smallpox Vaccine.
Carlin EP; Giller N; Katz R
Public Health Nurs; 2017 May; 34(3):200-209. PubMed ID: 27739111
[TBL] [Abstract][Full Text] [Related]
28. [Kaposi-Juliusberg's disease and atopic dermatitis, A clinical and immunopathologic approach (author's transl)].
Fernon MJ; Guillet G; Maleville J
Sem Hop; 1981 Feb 18-25; 57(7-8):347-52. PubMed ID: 6261368
[TBL] [Abstract][Full Text] [Related]
29. Adverse events occurring after smallpox vaccination.
Lane JM; Goldstein J
Semin Pediatr Infect Dis; 2003 Jul; 14(3):189-95. PubMed ID: 12913830
[TBL] [Abstract][Full Text] [Related]
30. [CAUSES OF GENERALIZED VACCINIA WITH ECZEMA VACCINATUM AND ITS TREATMENT WITH INACTIVATED SMALLPOX VACCINE].
EHRENGUT W
Med Welt; 1965 Apr; 17():937-9. PubMed ID: 14293912
[No Abstract] [Full Text] [Related]
31. Widespread eczema vaccinatum acquired by contacts. A report of an autopsy case.
Shirasawa K; Akai K; Kawaguchi Y; Maeda S; Nagahara S; Toyoda H; Kurata T
Acta Pathol Jpn; 1979 May; 29(3):435-55. PubMed ID: 377910
[TBL] [Abstract][Full Text] [Related]
32. Eczema vaccinatum: a reaction to the smallpox vaccine. A report of a rare but potentially lethal consequence.
Babic MJ
Am J Nurs; 2007 Aug; 107(8):30-1. PubMed ID: 17667384
[No Abstract] [Full Text] [Related]
33. Validation of a screening instrument to identify persons for exclusion from smallpox vaccination.
Belongia EA; Naleway A; Kieke B; Qutaishat S; Casey C; Shay DK; Chen RT
Clin Infect Dis; 2005 Feb; 40(4):620-3. PubMed ID: 15712089
[TBL] [Abstract][Full Text] [Related]
34. Validation and reproducibility of the International Study of Asthma and Allergies in Childhood (ISAAC) Written Atopic Eczema Questionnaire for telephone survey in children aged 6-7 years.
Oliveira EF; Penedo C; Valle SOR; Kuschnir FC
An Bras Dermatol; 2022; 97(2):173-178. PubMed ID: 34991900
[TBL] [Abstract][Full Text] [Related]
35. Viral infections in atopic dermatitis: pathogenic aspects and clinical management.
Wollenberg A; Wetzel S; Burgdorf WH; Haas J
J Allergy Clin Immunol; 2003 Oct; 112(4):667-74. PubMed ID: 14564342
[TBL] [Abstract][Full Text] [Related]
36. Self-reported lifetime prevalence of atopic dermatitis and co-morbidity with asthma and eczema in adulthood: a population-based cross-sectional survey.
Bingefors K; Svensson Å; Isacson D; Lindberg M
Acta Derm Venereol; 2013 Jul; 93(4):438-41. PubMed ID: 23306909
[TBL] [Abstract][Full Text] [Related]
37. [The clinical picture, differential diagnosis and treatment of so-called herpetic eczema in children].
Fomin KF; Fedorova VA
Vestn Dermatol Venerol; 1971; 45(3):26-30. PubMed ID: 5122539
[No Abstract] [Full Text] [Related]
38. Continuing mortality and morbidity from smallpox vaccination.
Du Mont GC; Beach RC
Br Med J; 1979 May; 1(6175):1398-9. PubMed ID: 445099
[TBL] [Abstract][Full Text] [Related]
39. Atopic dermatitis in young children: diagnostic criteria for use in epidemiological studies based on telephone interviews.
Benn CS; Benfeldt E; Andersen PK; Olesen AB; Melbye M; Björkstén B
Acta Derm Venereol; 2003; 83(5):347-50. PubMed ID: 14609101
[TBL] [Abstract][Full Text] [Related]
40. Expected adverse events in a mass smallpox vaccination campaign.
Kemper AR; Davis MM; Freed GL
Eff Clin Pract; 2002; 5(2):84-90. PubMed ID: 11990216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
